The HSV-1 alpha (immediate-early) protein ICP27 expressed in transfected cells can activate the expression of certain HSV-1 promoters as well as inhibit the transactivated expression of others. We constructed a set of plasmids encoding mutant ICP27 molecules truncated at their carboxyl termini and used transfection assays to determine the functional properties of the mutant proteins. A polypeptide containing the amino-terminal 263 amino acid residues of ICP27 retained partial ability to activate gene expression but was unable to inhibit transactivation. Mutant proteins possessing 406 or 504 amino acids of ICP27 were unable to activate gene expression but retained full ability to inhibit transactivation. These results define two separable regulatory activities of ICP27, one positive and one negative, which can modulate gene expression in transfected cells. Immunoblot and immunofluorescence experiments were used to study the immunological reactivities and intracellular localizations of the mutant proteins. All proteins possessing the amino-terminal 263 amino acids of ICP27 reacted with an ICP27-specific monoclonal antibody and were localized to the cell nucleus. The mutant proteins, however, exhibited a number of phenotypes with regard to intranuclear localization. A mutant possessing 504 residues of ICP27 was similar to the wild-type protein in apparently localizing to all regions of the nucleus. A mutant containing 406 residues of ICP27, on the other hand, was mostly excluded from the nucleolar regions, while a 263-residue mutant was localized predominantly in the nucleoli. Thus, some aspect of ICP27 structure or function can dramatically affect its intranuclear distribution.
The HSV-1 alpha (immediate-early) protein ICP27 expressed in transfected cells can activate the expression of certain HSV-1 promoters as well as inhibit the transactivated expression of others. We constructed a set of plasmids encoding mutant ICP27 molecules truncated at their carboxyl termini and used transfection assays to determine the functional properties of the mutant proteins. A polypeptide containing the amino-terminal 263 amino acid residues of ICP27 retained partial ability to activate gene expression but was unable to inhibit transactivation. Mutant proteins possessing 406 or 504 amino acids of ICP27 were unable to activate gene expression but retained full ability to inhibit transactivation. These results define two separable regulatory activities of ICP27, one positive and one negative, which can modulate gene expression in transfected cells. Immunoblot and immunofluorescence experiments were used to study the immunological reactivities and intracellular localizations of the mutant proteins. All proteins possessing the amino-terminal 263 amino acids of ICP27 reacted with an ICP27-specific monoclonal antibody and were localized to the cell nucleus. The mutant proteins, however, exhibited a number of phenotypes with regard to intranuclear localization. A mutant possessing 504 residues of ICP27 was similar to the wild-type protein in apparently localizing to all regions of the nucleus. A mutant containing 406 residues of ICP27, on the other hand, was mostly excluded from the nucleolar regions, while a 263-residue mutant was localized predominantly in the nucleoli. Thus, some aspect of ICP27 structure or function can dramatically affect its intranuclear distribution.
The expression of viral genes is tightly controlled during lytic infection of cells by herpes simplex virus type 1 (HSV-1) (2, 15, 19 ; for a review, see reference 35) . The 70 to 80 viral genes have been classified in part according to the kinetics of their expression. The viral alpha (immediateearly) genes are expressed first, followed by the beta (early) and then the gamma (late) genes. The classification of viral genes into three groups is also based on several other criteria. Alpha genes are distinguished by the fact that they are transcribed in the absence of prior viral protein synthesis, whereas beta and gamma gene transcription requires expression of the alpha proteins. Beta and gamma genes can be distinguished from each other on the basis of the effect of viral DNA replication on their expression. Expression of beta genes is not stimulated by viral DNA replication, whereas expression of gamma genes is stimulated by viral DNA replication. Gamma genes have been subdivided on the basis of the extent of this effect; gamma-1 genes are expressed at low levels even in the absence of DNA replication, while gamma-2 genes require DNA replication for significant expression. In addition to the regulated induction of HSV-1 genes during infection, there also exist poorly understood negative regulatory mechanisms which act to turn down alpha and beta gene expression when beta and gamma genes, respectively, are activated.
Each HSV-1 gene possesses its own promoter and is transcribed by the host cell RNA polymerase 11 (4) . The viral promoters contain recognizable TATA elements and, at least in the case of alpha and beta promoters, contain upstream sequence elements which are binding sites for cellular transcription factors (17, 18) . Thus, at the level of transcription, HSV-1 must depend to a large extent on the machinery of the host cell for the expression of its genes. However, in the * Corresponding author.
absence of functional alpha polypeptides, the ordered program of HSV-1 gene expression does not occur (16) . The alpha proteins presumably interact with the cellular machinery to either activate or inhibit the expression of the viral genes. Knowledge of how these viral regulatory proteins function is not only relevant to the biology of HSV-1 but may also provide some insight into how cellular gene expression can be modulated during such processes as signal transduction or development.
One alpha protein involved in viral gene regulation is ICP (infected-cell polypeptide) 27. ICP27 is a 63-kilodalton nuclear phosphoprotein expressed immediately after infection (1, 15, 20, 27, 30, 31) . Evidence that ICP27 is involved in gene regulation initially came from the phenotypic analysis of a set of HSV-1 mutants with temperature-sensitive (ts) mutations in the ICP27 gene (36) . At the nonpermissive temperature, these mutants are unable to activate a subset of beta and gamma genes and show enhanced expression of most alpha polypeptides. The ts mutations in the ICP27 gene have a differential effect on expression of the later (beta and gamma) genes; one gene which is expressed quite poorly by the mutants is the glycoprotein B (gB) gene (34) .
Additional evidence that ICP27 regulates gene expression comes from transient expression assays. These studies have shown that ICP27 expressed in transfected cells can alter the expression of many cotransfected HSV-1 target genes. Several studies have shown that ICP27 can induce expression of chimeric target genes driven by specific beta or gamma promoters (8, 34, 37, 39a) . For some of these promoters, the effect requires the expression of the HSV-1 alpha proteins ICP4, ICPO, or both. However, expression of ICP27 alone is able to stimulate expression of the gB promoter in transfected Vero cells, indicating that at least part of the positive regulatory effect of ICP27 is independent of other viral proteins. ICP27 is also able to inhibit gene expression from another set of chimeric genes driven by beta or gamma promoters (37, 39a) . The negative regulatory effect of ICP27 is complex in that ICP27 has little or no effect on the basal promoter activity of these genes but rather acts to counteract the stimulatory effect of the HSV-1 transactivating proteins ICP4 and ICPO.
In this study, we have constructed a set of mutant ICP27 genes that encode ICP27 molecules truncated at their carboxyl termini. Transient expression assays were used to determine the [34] ), pSHZ (encoding ICPO [28] ), and pSG1 (encoding ICP4 and ICPO [10] ) have been previously described. The plasmids pKl-2, which encodes ICP4 (7), and pIE3-CAT (6) were gifts from Neal DeLuca. The plasmid pgB-CAT(-175) contains the HSV-1 gB promoter (nucleotides -175 to +41 relative to the transcriptional start site) fused to the chloramphenicol acetyl transferase (CAT) gene and was previously called pgB-CAT-5'del(-175) (34 (formerly called pBHX1), which contains the XbaI termination linker at the Sall site of the ICP27 gene, was described previously (39a) . The plasmid pBH-59R was constructed by restricting pBH-263R with Rs.oII, which cuts twice within the ICP27-coding sequences. The 3'-recessed ends were repaired with the Klenow fragment, and an NheI linker con- (25) . In the cases of pBH-263R and pBH-406R, which encoded the 263R and 406R proteins, the linker DNA addition restored one wild-type codon followed by a stop codon so that no new additional amino acids were added. In the cases of pBH-59R and pBH-504R, the linker addition was predicted to create one and four novel carboxyl-terminal codons, respectively. Thus, pBH-59R was predicted to encode a 60-amino-acid polypeptide (59R) with a carboxyl-terminal serine residue, and pBH-504R was predicted to encode a 508-amino-acid polypeptide (504R) with carboxyl-terminal serine-serine-leucine-aspartate residues.
Transfections and CAT assays. Vero cells were transfected by using the calcium phosphate precipitation procedure as previously described (12, 34 To test whether the mutant genes expressed proteins of the predicted size, wild-type pBH27 or the mutant plasmids were transfected into Vero cells. Cell extracts prepared 2 days after transfection were subjected to sodium dodecyl sulfate-gel electrophoresis, and the separated proteins were transferred to a nitrocellulose filter. The filter was probed with H1113, a monoclonal antibody directed against HSV-1 ICP27 (1) (Fig. 2) . Both the wild-type pBH27 (Fig. 2, lane 1 (Fig. 3A and B) . In these cells, the protein was clearly localized to the nucleus. Cells transfected with the pBH-504R, pBH-406R, and pBH-263R plasmids also showed nuclear fluorescence (Fig. 3C, E (Fig. 3A and B) , although cells could be found in which one or the other compartment showed preferential staining. Cells expressing ICP27 often showed areas of intranuclear accumulation of ICP27, but these did not correspond to the nucleoli (Fig. 3A  and B) . The 504R protein was very similar to wild-type ICP27 in its pattern of intranuclear localization (Fig. 3C and  D) . The 406R protein, however, exhibited a general inability to localize efficiently to the nucleolar compartment of the nucleus (Fig. 3E and F) , although a small percentage of the positive cells (<20%) showed some nucleolar staining (not shown). Nearly all the cells expressing the 263R protein, on the other hand, showed preferential localization of the truncated ICP27 molecule to the nucleoli, with the rest of the nucleus staining more weakly ( Fig. 3G and H) . These results indicate that some aspect of ICP27 structure or function can dramatically influence the ability of the protein to localize within specific compartments of the cell nucleus.
Ability of the mutant polypeptides to transactivate gene expression. Wild-type ICP27 can transactivate expression of a gene containing the HSV-1 gB promoter fused to the CAT gene in transfected Vero cells (34) . To determine whether any of the truncated ICP27 molecules could also transactivate gB-CAT, we transfected a constant amount of the plasmid pgB-CAT(-175) with increasing amounts of wildtype or mutant ICP27 plasmid. CAT activities were determined in extracts prepared 2 days after transfection. As expected, the wild-type ICP27 greatly stimulated expression of the gB-CAT chimeric gene (Fig. 4) . Among the mutant polypeptides, only the 263R protein was able to stimulate CAT expression, although less efficiently than wild-type ICP27. This result is consistent with an earlier analysis in which the pBH-263R plasmid (previously called pBHX1) showed residual ability to stimulate gB-CAT expression (34) .
ICP27 is able to work in concert with ICP4, ICPO, or both to stimulate expression from the HSV-1 alkaline exonuclease gene or ICP5 gene promoters in transfected cells (8, 37, 39a ICP4, or ICPO alone did not induce significant expression of the gC-CAT gene. However, when both the ICP27 and ICP4 plasmids were cotransfected with pgC-CAT, a synergistic induction of CAT expression was observed. A similar but more dramatic synergistic effect was observed when the ICP27 and ICPO plasmids were cotransfected.
We determined which of the mutant ICP27 polypeptides could work in concert with ICP4 to stimulate gC-CAT expression. Vero cells were transfected with a constant amount of gC-CAT and pKl-2 (encoding ICP4) and increasing amounts of the wild-type or mutant ICP27 plasmids. As expected, ICP4 and the wild-type ICP27 efficiently induced gC-CAT expression (Fig. 5) . Among the mutant polypeptides, only the 263R protein was able to consistently act with ICP4 to induce gC-CAT expression, although much less efficiently than the wild-type ICP27. Thus, the ICP27 mutant polypeptides showed the same properties with respect to transactivation of both the gB and gC promoters in that only the 263R protein retains stimulatory activity.
Ability of the mutant polypeptides to inhibit HSV-1 gene transactivation. Wild-type ICP27 can inhibit the ability of ICP4 and ICPO to stimulate the expression of a chimeric gene in which the HSV-1 ICP8 gene promoter is linked to the CAT gene (39a) . To determine which of the mutant ICP27 gene products could inhibit ICP8 promoter transactivation, we transfected Vero cells with a constant amount of p8-CAT and pKl-2 (encoding ICP4) and increasing amounts of the wild-type or mutant ICP27 plasmids. Wild-type ICP27 and both the 406R and 504R mutant polypeptides were able to efficiently inhibit ICP4-activated expression from p8-CAT (Fig. 6) . However, neither the 59R nor the 263R polypeptides were able to significantly inhibit ICP4-mediated transactivation.
These results, in combination with those of the transactivation experiments, indicated that ICP27 possesses two different activities. The 263R polypeptide retains partial ability to transactivate the gB and gC promoters but has lost the ability to inhibit ICP4-mediated transactivation of the ICP8 promoter. Conversely, the 406R and 504R polypeptides have lost the ability to transactivate gene expression but retain full ability to inhibit transactivation. Because these two activities can be distinguished genetically, we conclude that they are separable activities of the ICP27 polypeptide.
Repression of transactivated gB-CAT expression by the 406R and 504R polypeptides. The 406R and 504R polypeptides have lost the ability to transactivate gB-CAT but retain full ability to inhibit the transactivated expression of 8-CAT. This raised the question of whether these proteins could inhibit the transactivated expression of the gB-CAT chimeric gene. Consistent with previous data (34), expression of ICP4 and ICPO transactivated gB-CAT (Fig. 7A) . Furthermore, wild-type ICP27 further induced the level of expression. The 59R polypeptide had no effect on the ability of ICP4 and ICPO to stimulate gB-CAT expression, while the 263R polypeptide had a small positive effect. This is consistent with a residual amount of transactivating ability possessed by the 263R protein. (6) (Fig. 7B) contains an integrated copy of the ICP27 gene and complements the growth of the mutant. Vero cells were transfected with control DNA, the wild-type ICP27 plasmid, or the mutant ICP27 plasmids. After 28 h, the cells were infected with d27-1 and allowed to undergo an infectious cycle. Virus yield was measured by plaque assay on V27 cells ( Table 2 ).
Transfection of the wild-type pBH27 plasmid increased significantly (80-fold) the yield of the mutant virus. In contrast, none of the mutant plasmids was able to significantly complement the growth of d27-1. Because the HSV-1 insert in the plasmid and the deletion in d27-1 are nonoverlapping, it is not possible to generate wild-type recombinants by homologous recombination in this experiment. Therefore, the increase in viral titer was due to complementation of ICP27 function by the transfected plasmid. The results of this experiment suggest that each mutant polypeptide is defective for a function of ICP27 required for lytic growth. However, because the 263R protein appeared to be expressed in lesser amounts in transfected cells compared with the wild-type protein (Fig. 2) , we cannot exclude the possibility that this protein fails to complement d27-1 growth at least in part because of its reduced level of accumulation. DISCUSSION Identification of two separable ICP27 regulatory activities. Previous studies have indicated that the HSV-1 alpha protein ICP27 can either positively or negatively modulate expression of certain HSV-1 promoters in transient expression assays. In this study, similar assays were used to examine the functional properties of a set of truncated derivatives of ICP27 (summarized in Table 3 ). The mutant polypeptides showed three phenotypes with regard to their abilities to affect gene expression. The 504R and 406R mutants were defective for the ICP27 transactivation function but retained full ability to inhibit ICP4-mediated transactivation of the ICP8 gene promoter. The 263R polypeptide, on the other hand, retained partial transactivation activity but was defective for inhibition of ICP8 promoter transactivation. Lastly, the 59R protein was nonfunctional in both gene expression assays. These results indicate that ICP27 possesses two genetically separable activities which can modulate gene expression in transfected cells. One activity had a positive effect on gene expression, while the other inhibited gene expression. In this respect, ICP27 is similar to the adenovirus Ela proteins, which also contain two separable activities which up or down regulate gene expression in trans (26) .
The conclusion that ICP27 possesses both positive and negative regulatory functions is consistent with the pheno- The fact that the wild-type ICP27 and some of its derivatives can efficiently localize to the nucleolus suggests that the protein contains a structure or function which confers this ability. A nucleolar localization signal, if its exists, could be dependent on or independent of a nuclear localization signal. A short polypeptide sequence conferring nucleolar localization has recently been identified in the p27x-"' regulatory protein of human T-cell leukemia virus type I (39) . If ICP27 possesses a similar signal, it must be located within the first 263 amino acid residues, since the 263R protein is localized to the nucleolus. If this is the case, however, it is not clear why the longer 406R protein does not accumulate efficiently in the nucleolus.
Transfection assays as probes of ICP27 function. The transfection assays described here provide a reasonable strategy for determining several properties of mutant ICP27 polypeptides (Table 3) . Included in these are the ability of the protein to activate or repress gene expression, to localize into and within the cell nucleus, and to bind to a monoclonal antibody. In addition, it is possible to test whether mutant ICP27 molecules will complement the growth of an HSV-1 ICP27 null mutant. None of the truncated ICP27 polypeptides we tested, however, retained any ability to complement d27-1 growth, suggesting that each mutation has inactivated some essential function of ICP27. This is perhaps most surprising for the 504R mutant, which encodes a polypeptide in which only the last 8 of the 512 amino acids of ICP27 have been deleted and 4 novel amino acids have been inserted in their place. It is worth noting in this regard that the carboxylterminal portion of ICP27 is the region of the protein most highly conserved among the homologous herpesvirus proteins (5, 29) .
The transfection assays are limited in two important respects with regard to information they can provide about ICP27 function. First, only a small percentage of cells are successfully transfected, making it difficult to perform biochemical or molecular biological analyses which might delineate mechanisms by which ICP27 modulates gene expression. In this regard, although our working model is that ICP27 is a transcriptional regulatory protein, the data obtained from transfection experiments do not directly test this hypothesis. The second limitation is that the transfection assays cannot fully mimic the complex regulatory interactions that occur in HSV-1-infected cells. It is therefore vital to extend the genetic analysis of ICP27 to the context of the viral genome. In this way, specific models for ICP27 action, such as transcriptional regulation, can be directly tested. Furthermore, the effects of defined ICP27 mutations can be evaluated in the complex setting of the infected cell. It would be of special interest to study the phenotypes of HSV-1 mutants lacking ICP27 function entirely or possessing only one or the other of the two regulatory activities which we have identified in transfected cells.
